These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2002545)

  • 21. Prolonged infection in rhesus macaques with simian immunodeficiency virus (SIVmac239) results in animal-specific and rarely tissue-specific selection of nef variants.
    Zhu GW; Mukherjee S; Sahni M; Narayan O; Stephens EB
    Virology; 1996 Jun; 220(2):522-9. PubMed ID: 8661405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation of the SIVagm transmembrane glycoprotein in naturally and experimentally infected primates.
    Fomsgaard A; Johnson PR; London WT; Hirsch VM
    AIDS; 1993 Aug; 7(8):1041-7. PubMed ID: 8397939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simian immunodeficiency virus (mac 251-32H) transmembrane protein sequence remains conserved throughout the course of infection in macaques.
    Slade A; Jones S; Almond N; Kitchin P
    AIDS Res Hum Retroviruses; 1993 Feb; 9(2):133-9. PubMed ID: 8457380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.
    Rud EW; Cranage M; Yon J; Quirk J; Ogilvie L; Cook N; Webster S; Dennis M; Clarke BE
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():529-43. PubMed ID: 8126450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.
    Overbaugh J; Rudensey LM; Papenhausen MD; Benveniste RE; Morton WR
    J Virol; 1991 Dec; 65(12):7025-31. PubMed ID: 1942255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Letvin NL
    J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIV vaccine protection of rhesus monkeys.
    Gardner MB; Carlson JR; Jennings M; Rosenthal A; Langlois A; Haynes B; Bolognesi D; Palker TJ
    Biotechnol Ther; 1991; 2(1-2):9-19. PubMed ID: 1845125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.
    Naidu YM; Kestler HW; Li Y; Butler CV; Silva DP; Schmidt DK; Troup CD; Sehgal PK; Sonigo P; Daniel MD
    J Virol; 1988 Dec; 62(12):4691-6. PubMed ID: 2846880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.
    Schmitz JE; Johnson RP; McClure HM; Manson KH; Wyand MS; Kuroda MJ; Lifton MA; Khunkhun RS; McEvers KJ; Gillis J; Piatak M; Lifson JD; Grosschupff G; Racz P; Tenner-Racz K; Rieber EP; Kuus-Reichel K; Gelman RS; Letvin NL; Montefiori DC; Ruprecht RM; Desrosiers RC; Reimann KA
    J Virol; 2005 Jul; 79(13):8131-41. PubMed ID: 15956558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmembrane protein of SIV.
    Cranage MP; Almond N; Jenkins A; Kitchin PA
    Nature; 1989 Nov; 342(6248):349. PubMed ID: 2685605
    [No Abstract]   [Full Text] [Related]  

  • 35. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
    Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant.
    Nyambi PN; Lewi P; Peeters M; Janssens W; Heyndrickx L; Fransen K; Andries K; Vanden Haesevelde M; Heeney J; Piot P; van der Groen G
    J Virol; 1997 Mar; 71(3):2320-30. PubMed ID: 9032368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.
    Kent SJ; Stallard V; Corey L; Hu SL; Morton WR; Gritz L; Panicali DL; Greenberg PD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):551-60. PubMed ID: 7917517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
    Kinsey NE; Anderson MG; Unangst TJ; Joag SV; Narayan O; Zink MC; Clements JE
    Virology; 1996 Jul; 221(1):14-21. PubMed ID: 8661410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.
    Buge SL; Richardson E; Alipanah S; Markham P; Cheng S; Kalyan N; Miller CJ; Lubeck M; Udem S; Eldridge J; Robert-Guroff M
    J Virol; 1997 Nov; 71(11):8531-41. PubMed ID: 9343211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.